Monday, 22 August 2016

Genomics Personalized Health Market – Global Industry Analysis and Forecast 2016 – 2024

Genomics Personalized Health Market: Overview 
Personalized genomics is a branch of genomics that is concerned with the analysis and sequencing of an individual’s genome. The genotype of an individual can be identified using various techniques such as next-generation sequencing (NGS), partial genome sequencing, single-nucleotide polymorphism (SNP) analysis, and full genome sequencing. After identifying an individual’s genotype, it is compared with published literature to determine trait expressions and the probability of acquiring certain diseases. 
Personalized genomics play an imperative role in personalized and predictive medicine. With recent developments in gene sequencing techniques and data analytics, genetic testing technology is evolving rapidly. It is also expected that with the decreasing costs of genetic testing, personalized genomics is likely to become affordable for everyone in the near future, which will transform the genomics personalized health market into a highly lucrative business prospect.
Genomics Personalized Health Market: Key Segments
Some of the types of instruments generally used in personalized genomics are NGS platforms, RT-PCR, microarray, and sequencing and genetic analyzers. Some of the types of genetic tests used in personalized genomics are oncology testing, infectious disease testing, orphan disease testing, autoimmune disease testing, and obstetrics testing. Genomics personalized health market players offer various services such as genomic sequencing services, microarray services, and the software used to store the data gained from the genetic analysis.
Genomics Personalized Health Market: Region-wise Outlook 
In terms of geography, North America, followed by Europe, accounts for the largest share in the global genomics personalized health market owing to the high adoption rate of genetic testing services and the high prevalence of cancer and other autoimmune diseases in developed countries. According to the American Cancer Society, in 2014, approximately 232,670 women were diagnosed with invasive breast cancer in the U.S. Additionally, the WHO reported that, in 2012, about 8.2 million people died of cancer and approximately 1.7 million women were diagnosed with breast cancer globally.
The demand for novel diagnostic and treatment solutions such as genetic testing solutions and personalized medicine is expected to remain high in developed countries such as the U.S, Germany and the U.K. in the coming years. However, other regions such as Asia Pacific, the Middle East, and Latin America are expected to become major markets in the near future, owing to the increasing demand for advanced diagnostics solutions and research applications.
Genomics Personalized Health Market: Drivers and Restraints 
The genomics personalized health market has witnessed significant growth in the last few years. The major factor propelling the genomics personalized health market is the expanding application of genomic testing and research.
Moreover, other factors such as technological advancements in whole genome and next-generation sequencing and the growing consumer adoption rate are also contributing to the growth of the genomics personalized health market. Furthermore, favorable reimbursement models, increasing government investments in genetic research projects and the implementation of better regulatory policies in approval pathways are driving the genomics personalized health market. However, factors such as the high cost of gene sequencing, delay in regulatory approvals, and the decreasing average selling prices of genomics services and instruments are some of the factors that can hinder the growth of the genomics personalized health market.
Genomics Personalized Health Market: Competitive Insight 
Presently, the global genomics personalized health market is highly competitive owing to the involvement of many established players. The major companies involved in the genomics personalized health market  are Bio-Rad Laboratories, Inc., Eastern Biotech & Life Sciences, Gene By Gene, LTD., Genelex Corporation, Genetic Technologies Group, Genotek, InoLife Technologies, Inc., Illumina, Inc., Indian Biosciences, Invitae, Interleukin Genetics, Life Technologies, Corp., Knome, Inc., Roche Diagnostic, QIAGEN, uBiome, Inc., Xcode Life Sciences.
Browse Research Report on Global Genomics Personalized Health Market:
http://www.transparencymarketresearch.com/personalized-genomics-market.html

Monday, 11 August 2014

Report on Life Sciences Tools Market - Global Analysis, Industry Segments and Forecast, 2013 – 2019

Transparency Market Research Reports incorporated a definite business overview and investigation inclines on “Life Sciences Tools Market”. This report likewise incorporates more illumination about fundamental review of the business including definitions, requisitions and worldwide business sector industry structure. Life science is the field of science that deals with the study of variety of living organisms, such as, plants, animals, human beings and microorganisms. Life sciences is also considered as a multidisciplinary scientific and research field as it comprises of a wide number of fields of study, such as molecular biology, genetics, biotechnology, cell biology, biochemistry, biomedicine etc. Some of the major life sciences tools include, instruments, reagents, consumables and services that are offered to various academic, medical, scientific and research professionals worldwide.
Life sciences tools market can be classified into five major segments, namely, genomics, proteomics, cell biology, other analytical tools and laboratory supplies & disposables. The genomics tools segment can be further classified into sub segments, such as, PCR, digital PCR, qPCR, CE sequencing, microarrays, next generation/third generation sequencing and molecular biology. The proteomics tools can be further segmented into segments such as, ELISA, protein isolation and analysis, protein microarrays, protein production and western blotting tools. And, the other analytical tools will include, media and sera, basic cell biology reagents, flow cytometry, electroporation, transfection, microscopy, cell culture equipment, whole cell imaging, cells and tissues. The laboratory supplies and disposables include sub segments such as, mass spectroscopy, liquid chromatography, multiplex technologies, in vivo study, sample preparation, glassware, LIMS and magnetic beads.
Some of the major driving factors for the growth of life sciences tools market include, rising demand from various research and pharmaceutical companies, increasing incidences of new and drug resistant diseases and technological advancement in various fields of life sciences. Various research and pharmaceutical companies increasingly demand for better and improved reagents and other instruments that will add to their faster research and drug development processes. Also, various life science tools do not face strict regulations for their approval and marketing such as other drugs and other medical devices. Increasing incidences of infectious diseases and related research and development of new treatment methods require assistance of various life science tools, which will further help in the growth of this market. Current ongoing innovations and technological advancements in life science instruments will add to the growth of life sciences tools market in the near future.
Geographically, North America dominates the life sciences tools market followed by Europe. Major factors responsible for the growth of this market in these regions were high rate of research and drug development activities in the region and most of the research and big pharmaceutical firms are located in these regions. However, Asia-Pacific represents the most lucrative market for the life sciences tools due to its rapid rate of growth in recent past. The major factors responsible for this region’s fast rate of growth include increasing demand for various life sciences tools due to rising healthcare expenditure in the region along with the rising economic condition of various countries of the region.
Some of the major players operating in the life sciences tools market are Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., EMD Millipore (Merck KGaA), Life Technologies (Thermo Fisher Scientific Corporation), F. Hoffmann-La Roche Ltd. and Sigma-Aldrich Corporation.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  • North America
  • Asia Pacific
  • Europe
  • Rest of the World
This report provides comprehensive analysis of
  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
About Us
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY — 12207
United States
Tel: +1-518-618-1030
USA — Canada Toll Free 866-552-3453

Browse Market Research Blogs: